Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study-Reference-Cited by-同舟云学术

Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study

Published:2022-08-22 Issue:3 Volume:72 Page:591-598
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Sawa Kenji,Sato Izumi,Takeuchi Masato,Kawakami Koji^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03281-7.pdf

Reference27 articles.

1. Omori T, Tajiri M, Baba T, Ogura T, Iwasawa T, Okudela K et al (2015) Pulmonary resection for lung cancer in patients with idiopathic interstitial pneumonia. Ann Thorac Surg 100(3):954–960. https://doi.org/10.1016/j.athoracsur.2015.03.094

2. Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K et al (2014) Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 147(5):1604–11 e3. https://doi.org/10.1016/j.jtcvs.2013.09.050

3. Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y et al (2011) The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 6(7):1242–1246. https://doi.org/10.1097/JTO.0b013e318216ee6b

4. Kenmotsu H, Naito T, Mori K, Ko R, Ono A, Wakuda K et al (2015) Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease. Cancer Chemother Pharmacol 75(3):521–526. https://doi.org/10.1007/s00280-014-2670-y

5. Minegishi Y, Sudoh J, Kuribayasi H, Mizutani H, Seike M, Azuma A et al (2011) The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 71(1):70–74. https://doi.org/10.1016/j.lungcan.2010.04.014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Anatomical Pulmonary Segmentectomy and Lobectomy under Uniportal Video-Assisted Thoracoscopic Surgery on Cardiopulmonary Function and Serum Tumor Markers in Patients with Early-Stage Non-Small Cell Lung Cancer;Annali Italiani di Chirurgia;2024-08-20

2. Are Immune Checkpoint Inhibitors Safe and Effective in Lung Cancer Patients with Pre-Existing Interstitial Lung Disease?;Immunotherapy;2024-03-21

3. Immune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease;Biological and Pharmaceutical Bulletin;2024-02-20

4. Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study;Clinical Lung Cancer;2023-11

5. Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review);International Journal of Oncology;2023-09-06